Routine ctDNA-MRD (Physician Webinar)
NOV
20
Friday, November 20
9:00 AM - 9:30 AM
From sample to result: evidence, test procedure, logistics and reimbursement
Dr. Sven Borchmann will introduce the concept of the liquid biopsy ctDNA-MRD test, presenting the current clinical evidence for using this test in cancer treatment. He will also discuss the available options and the value of incorporating this test into routine diagnostics. You will then have the opportunity to ask Dr. Borchmann any questions you may have.
Speaker
Sven Borchmann
Founder & CEO @ LIQOMICS
ctDNA-based MRD diagnostics for lymphoma & solid tumors | MD, PhD | Principal Investigator @ University of Cologne
NOV
20
Friday, November 20
9:00 AM - 9:30 AM